On the basis of next generation sequencing technologies GATC Biotech and LifeCodexx will develop a human genetic diagnostic test that will allow the detection of cell-free fetal DNA as an important early marker for Preeclampsia. The test would allow a reliable risk assessment before symptoms appear. The project is supported by grants from the KMU Innovation Program of the Federal Ministry for Research and Education with 500,000 Euros over the next two years.
"Currently there is no reliable method to predict preeclampsia. This new genetic test will therefore provide additional assurance early in pregnancy," said Dr. Wera Hofmann, Medical Director of LifeCodexx AG.
"We will immediately investigate the new PacBio RS technology for use in the test protocol. This sequencing system of the Third Generation can analyze single molecules in real-time within minutes. Costs and duration of the diagnostic test could be drastically reduced,” added Peter Pohl, CEO of GATC Biotech and chairman of LifeCodexx.
“We are pleased to have a second diagnostic test in our development pipeline, in addition to the non-invasive prenatal diagnostic test for the determination of trisomy 21. It is another step forward towards our goal to become a leader in the field of Next Generation Molecular Diagnostics,” said Dr. Michael Lutz, CEO of LifeCodexx AG.
Eurofins scientific acquires two North American companies
By acquiring EnvironeX Group Inc. in Canada and TestAmerica in the USA Eurofins expands its testing capabilities in the North American market. EnvironeX Group Inc. - bioanalytical testing in Canada Founded in 2005 by Marc Hamilton and supported by PCP since 2015, EnvironeX is a leading prov ... more
Eurofins acquires German pharma quality service company
Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more
Eurofins expands its footprint in Asia with the acquisition of Lab Frontier in South Korea
Eurofins Scientific (EUFI.PA) announces that it has successfully closed the transaction to acquire Lab Frontier Co., Ltd., which provides a broad suite of food, environment and cosmetics testing services in South Korea. Lab Frontier, an affiliate company of Young In Group (YIG), will furthe ... more
Agilent Technologies Sales & Services GmbH & Co. KG
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and ... more
Azenta, Inc. Corporate Headquarters
We are Azenta Life Sciences. We provide unrivaled sample exploration and management solutions to help our customers accelerate discovery, development and delivery. Azenta Life Sciences Services and Products business is rebranded under the creation of a new identity – Azenta Life Sciences. ... more
Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make t ... more
HAMILTON Robotics designs and manufactures fully automated robotic systems. The products range from unique, custom laboratory automation solutions (Turnkey Solutions) on standard applications validated through partnership programs with renowned biotechnology companies as well as OEM solutio ... more
BioTek is a leading developer and supplier of high-value microplate instrumentation and software solutions. Our instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research. As par ... more
Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research
CureVac N.V. has received notification from the German Federal Ministry of Education and Research (BMBF) that CureVac is expected receive up to 252 million euros to support the development of its COVID-19 vaccine candidate. In July 2020, CureVac had applied to a grant as part of a special p ... more
amcure Awarded BMBF Research Grant Supporting Plans to Advance Lead Candidate into Clinic in 2016
amcure announced the award of an approximately €1.9 million grant by the German Ministry of Education and Research (BMBF). The grant covers half the investment needed to advance amcure’s lead candidate through preclinical and into clinical development with the other half coming from a conso ... more
